LungLife AI (LLAI) Competitors GBX 8.75 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors LLAI vs. VRCI, PRM, GENI, IDHC, DMTR, LLA, DXRX, AGL, YGEN, and ABDXShould you be buying LungLife AI stock or one of its competitors? The main competitors of LungLife AI include Verici Dx (VRCI), Proteome Sciences (PRM), GENinCode (GENI), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), LLA.L,0P0001T9GN,0 (LLA), Diaceutics (DXRX), ANGLE (AGL), Yourgene Health (YGEN), and Abingdon Health (ABDX). These companies are all part of the "diagnostics & research" industry. LungLife AI vs. Verici Dx Proteome Sciences GENinCode Integrated Diagnostics Deepmatter Group LLA.L,0P0001T9GN,0 Diaceutics ANGLE Yourgene Health Abingdon Health Verici Dx (LON:VRCI) and LungLife AI (LON:LLAI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation, dividends and community ranking. Does the MarketBeat Community favor VRCI or LLAI? Verici Dx and LungLife AI both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformVerici DxN/AN/ALungLife AIN/AN/A Is VRCI or LLAI more profitable? LungLife AI has a net margin of 0.00% compared to Verici Dx's net margin of -110.99%. LungLife AI's return on equity of -48.59% beat Verici Dx's return on equity.Company Net Margins Return on Equity Return on Assets Verici Dx-110.99% -58.12% -26.14% LungLife AI N/A -48.59%-27.28% Which has more volatility and risk, VRCI or LLAI? Verici Dx has a beta of 1.59, suggesting that its stock price is 59% more volatile than the S&P 500. Comparatively, LungLife AI has a beta of -0.3, suggesting that its stock price is 130% less volatile than the S&P 500. Does the media refer more to VRCI or LLAI? In the previous week, Verici Dx's average media sentiment score of 0.00 equaled LungLife AI'saverage media sentiment score. Company Overall Sentiment Verici Dx Neutral LungLife AI Neutral Do insiders & institutionals have more ownership in VRCI or LLAI? 51.9% of Verici Dx shares are held by institutional investors. Comparatively, 42.5% of LungLife AI shares are held by institutional investors. 17.1% of Verici Dx shares are held by company insiders. Comparatively, 48.4% of LungLife AI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger earnings & valuation, VRCI or LLAI? LungLife AI has lower revenue, but higher earnings than Verici Dx. Verici Dx is trading at a lower price-to-earnings ratio than LungLife AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVerici Dx£4.33M1.89-£4.81M-£0.02-168.75LungLife AI£98.57K27.22-£4.47M-£0.13-67.31 SummaryLungLife AI beats Verici Dx on 6 of the 11 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get LungLife AI News Delivered to You Automatically Sign up to receive the latest news and ratings for LLAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLAI vs. The Competition Export to ExcelMetricLungLife AIDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£2.68M£26.21M£5.09B£1.42BDividend YieldN/A5.44%5.04%11.56%P/E Ratio-67.311.91101.481,569.60Price / Sales27.222,191.961,207.98219,445.82Price / Cash2.289.9539.7133.65Price / Book0.312.346.932.81Net Income-£4.47M£45.44M£118.81M£157.07M7 Day Performance9.38%2.09%-1.39%-0.63%1 Month Performance-14.63%-3.44%-3.29%3.20%1 Year Performance-90.30%7.42%32.29%97.44% LungLife AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLAILungLife AIN/AGBX 8.75flatN/A-90.7%£2.68M£98,566.00-67.3115VRCIVerici DxN/AGBX 3.38flatN/A-65.7%£8.19M£4.33M-168.7519PRMProteome SciencesN/AGBX 2.75flatN/A-54.2%£8.12M£4.04M-230.00240Gap DownGENIGENinCodeN/AGBX 4.18+0.7%N/A-44.0%£7.40M£2.60M-83.602,300Gap DownIDHCIntegrated DiagnosticsN/AGBX 0.38-2.6%N/A+18.2%£2.21M£4.75B12.336,692Gap DownDMTRDeepmatter GroupN/AGBX 0.03+22.2%N/A+0.0%£1.33M£1.04M-0.11N/AGap DownLLALLA.L,0P0001T9GN,0N/AGBX 15flatN/AN/A£0.00N/A-125.0015High Trading VolumeDXRXDiaceuticsN/AGBX 117.10-1.2%GBX 160+36.6%+32.6%£98.91M£26.09M-3,933.33151AGLANGLE1.2384 of 5 starsGBX 11-4.3%GBX 70+536.4%+9.5%£35.48M£2.02M-157.14650YGENYourgene HealthN/AGBX 0.52flatN/A+0.0%£16.43M£29.67M-51.50253ABDXAbingdon HealthN/AGBX 7.25flatN/A-32.5%£13.74M£6.13M-899.0084News Coverage Related Companies and Tools Related Companies Verici Dx Competitors Proteome Sciences Competitors GENinCode Competitors Integrated Diagnostics Competitors Deepmatter Group Competitors LLA.L,0P0001T9GN,0 Competitors Diaceutics Competitors ANGLE Competitors Yourgene Health Competitors Abingdon Health Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:LLAI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LungLife AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LungLife AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
